Jump Financial »

Atrium Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $417k 31k 13.45

More positions owned by Jump Financial

State Street SPDR S&P 500 ETF Trust Etf (SPY)
iShares Core S&P 500 ETF Etf (IVV)
Invesco QQQ Trust Series 1 Etf Call Option (QQQ)
Direxion Daily Semiconductor Bull 3X ETF Etf (SOXL)
iShares Russell 2000 ETF Etf Call Option (IWM)
Vanguard S&P 500 ETF Etf (VOO)
iShares iBoxx USD High Yield Corporate Bond ETF Etf Call Option (HYG)
Bloom Energy Corp Common Stock (BE)
Sandisk Corp Common Stock (SNDK)
iShares MSCI South Korea ETF Etf (EWY)
iShares 20 Year Treasury Bond ETF Etf Call Option (TLT)
Seagate Technology Holdings Common Stock (STX)
Super Micro Computer Convertible bond (Principal)
Western Digital Corp Common Stock (WDC)
Intel Corp Common Stock (INTC)

View all positions for Jump Financial

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
Sessa Capital IM
BlackRock
Susquehanna International
Vanguard Capital Management
CRCM
TIG Advisors
Geode Capital Management
Two Sigma Investments
Goldman Sachs Group
683 Capital Management
Fort Hoosac Management
State Street Corporation
Cantor Fitzgerald, L. P.
Slotnik Capital

View all funds holding Atrium Therapeutics